Stockreport

How Investors May Respond To Neurocrine Biosciences (NBIX) INGREZZA Real-World Persistence Edge Over AUSTEDO XR [Yahoo! Finance]

Neurocrine Biosciences, Inc.  (NBIX) 
Last neurocrine biosciences, inc. earnings: 2/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: neurocrine.com/about-us/webcasts-presentations
PDF longer and switched less often than matched patients on AUSTEDO XR over six months, based on 2,988 U.S. patients in an IQVIA LAAD retrospective analysis completed betwee [Read more]